Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04295863
Title Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications

Advanced Solid Tumor

Therapies

Nivolumab

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University Of Chicago Medicine Comprehensive Cancer Center Recruiting Chicago Illinois 60637 United States Details
SSM Health Cancer Care Recruiting Madison Wisconsin 53717 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field